Literature DB >> 2205272

Renal tubular acidosis.

J Rodríguez-Soriano1, A Vallo.   

Abstract

The term renal tubular acidosis (RTA) is applied to a group of transport defects in the reabsorption of bicarbonate (HCO3-), the excretion of hydrogen ions, or both. On clinical and pathophysiological grounds, RTA can be separated into three main types: distal RTA (type 1), proximal RTA (type 2) and hyperkalaemic RTA (type 4). Some patients present combined types of proximal and distal RTA or of hyperkalaemic and distal RTA. Diagnosis of RTA should be suspected when a patient presents a normal plasma anion gap, and hyperchloraemic metabolic acidosis. A normal plasma anion gap (Na(+)-[Cl- + HCO3-] = 8-16 mEq/l) reflects loss of HCO3- from the extracellular fluid via the gastro-intestinal tract or the kidney, dilution of extracellular buffer or administration of hydrochloric acid (HCl) or its precursors. Distinction of RTA from other disorders is greatly facilitated by the study of the urine anion gap (Na+ + K+ - Cl-). This index estimates the urinary concentration of ammonium in a patient with hyperchloraemic metabolic acidosis. A negative urine anion gap (Cl- much greater than Na+ + K+) suggests the presence of gastro-intestinal or renal loss of HCO3-, while a positive urine anion gap (Cl- less than Na+ + K+) is indicative of a distal acidification defect. Determination of plasma potassium, of urine pH at low plasma HCO3- concentration, and of urine PCO2 and fractional excretion of HCO3- at normal plasma HCO3- concentration permits the differentiation between the various types of RTA.

Entities:  

Mesh:

Year:  1990        PMID: 2205272     DOI: 10.1007/bf00857675

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  49 in total

Review 1.  Physiology and cell biology update: control mechanisms for bicarbonate secretion.

Authors:  V L Schuster
Journal:  Am J Kidney Dis       Date:  1989-04       Impact factor: 8.860

Review 2.  Recent advances in the cellular mechanisms and hormonal regulation of urine acidification.

Authors:  M Paillard; M Bichara
Journal:  Adv Nephrol Necker Hosp       Date:  1989

3.  The use of the urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis.

Authors:  D C Batlle; M Hizon; E Cohen; C Gutterman; R Gupta
Journal:  N Engl J Med       Date:  1988-03-10       Impact factor: 91.245

4.  Acquired distal renal tubular acidosis.

Authors:  N A Kurtzman
Journal:  Kidney Int       Date:  1983-12       Impact factor: 10.612

Review 5.  Mechanisms of active H+ secretion in the proximal tubule.

Authors:  P S Aronson
Journal:  Am J Physiol       Date:  1983-12

6.  The natural history of distal renal tubular acidosis.

Authors:  O M Wrong; T G Feest
Journal:  Contrib Nephrol       Date:  1980       Impact factor: 1.580

Review 7.  The clinical spectrum of renal tubular acidosis.

Authors:  L L Rocher; R L Tannen
Journal:  Annu Rev Med       Date:  1986       Impact factor: 13.739

8.  Renal tubular acidosis in infants: the several kinds, including bicarbonate-wasting, classic renal tubular acidosis.

Authors:  E McSherry; A Sebastian; R C Morris
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

9.  Renal membrane-bound carbonic anhydrase. Purification and properties.

Authors:  P J Wistrand; K G Knuuttila
Journal:  Kidney Int       Date:  1989-03       Impact factor: 10.612

10.  Hydrogen ion secretion by the collecting duct as a determinant of the urine to blood PCO2 gradient in alkaline urine.

Authors:  T D DuBose
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

View more
  19 in total

1.  Deferasirox-induced serious adverse reaction in a pediatric patient: pharmacokinetic and pharmacogenetic analysis.

Authors:  M Marano; G Bottaro; B Goffredo; F Stoppa; M Pisani; A M Marinaro; F Deodato; C Dionisi-Vici; E Clementi; F S Falvella
Journal:  Eur J Clin Pharmacol       Date:  2015-09-24       Impact factor: 2.953

2.  Fanconi-Bickel syndrome as an example of marked allelic heterogeneity.

Authors:  Mohammad Al-Haggar
Journal:  World J Nephrol       Date:  2012-06-06

3.  Specificity of pH and osmolality of early morning urine sample in assessing distal renal tubular function in children: results in healthy children.

Authors:  R Skinner; M Cole; A D Pearson; M G Coulthard; A W Craft
Journal:  BMJ       Date:  1996-05-25

4.  Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis.

Authors:  F E Karet; F J Gainza; A Z Györy; R J Unwin; O Wrong; M J Tanner; A Nayir; H Alpay; F Santos; S A Hulton; A Bakkaloglu; S Ozen; M J Cunningham; A di Pietro; W G Walker; R P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  Hyperammonaemia with distal renal tubular acidosis.

Authors:  S G Miller; G J Schwartz
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

Review 6.  Assessment of chemotherapy-associated nephrotoxicity in children with cancer.

Authors:  R Skinner; A D Pearson; M G Coulthard; A W Skillen; A W Hodson; M E Goldfinch; I Gibb; A W Craft
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 7.  Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Pediatr Nephrol       Date:  2010-06-05       Impact factor: 3.714

Review 8.  Distal renal tubular acidosis: the value of urinary pH, PCO2 and NH4+ measurements.

Authors:  O Wrong
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

9.  Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two cases.

Authors:  R Rossi; U Helmchen; G Schellong
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

10.  Pathophysiology of the renal acidification defect present in the syndrome of familial hypomagnesaemia-hypercalciuria.

Authors:  J Rodríguez-Soriano; A Vallo
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.